These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2529368)

  • 1. Atrial natriuretic peptide blocks the renal vasoconstrictor response to hypertonic saline in the dog.
    Gerber JG; Bedell KS; Nies AS
    J Pharmacol Exp Ther; 1989 Oct; 251(1):77-81. PubMed ID: 2529368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between angiotensin II and adenosine in mediating the vasoconstrictor response to intrarenal hypertonic saline infusions in the dog.
    Deray G; Sabra R; Herzer WA; Jackson EK; Branch RA
    J Pharmacol Exp Ther; 1990 Feb; 252(2):631-5. PubMed ID: 2179530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminophylline inhibits renal vasoconstriction produced by intrarenal hypertonic saline.
    Gerkens JF; Heidemann HT; Jackson EK; Branch RA
    J Pharmacol Exp Ther; 1983 Jun; 225(3):611-5. PubMed ID: 6864522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal vasoconstrictor response to hypertonic saline in the dog: effects of prostaglandins, indomethacin and theophylline.
    Gerber JG; Nies AS
    J Physiol; 1986 Nov; 380():35-43. PubMed ID: 3302211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the natriuretic activity in the suprahepatic plasma after portal hypertonic NaCl infusion in dogs.
    Zubiaur M; Peces R; Mombiela MT; López-Novoa JM; Hernando L
    Acta Physiol Lat Am; 1981; 31(2):129-37. PubMed ID: 7187585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saline-induced natriuresis and renal blood flow in conscious dogs: effects of sodium infusion rate and concentration.
    Sandgaard NC; Andersen JL; Holstein-Rathlou NH; Bie P
    Acta Physiol Scand; 2005 Nov; 185(3):237-50. PubMed ID: 16218929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of renal vasoconstriction induced by intrarenal hypertonic saline by the nonxanthine adenosine antagonist CGS 15943A.
    Callis JT; Kuan CJ; Branch KR; Abels BC; Sabra R; Jackson EK; Branch RA
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1123-9. PubMed ID: 2703965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the natriuretic hormone in the specific natriuresis induced by intraportal infusion of hypertonic saline in dogs.
    Zubiaur M; Fernandez Muñoz MD; Hernando L; Lopez-Novoa JM
    Miner Electrolyte Metab; 1987; 13(1):13-8. PubMed ID: 3587179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of brain natriuretic peptide on renin secretion in normal and hypertonic saline-infused kidney.
    Akabane S; Matsushima Y; Matsuo H; Kawamura M; Imanishi M; Omae T
    Eur J Pharmacol; 1991 Jun; 198(2-3):143-8. PubMed ID: 1864303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic peptide counteracts angiotensin-II-induced impairment of renal function.
    Schafferhans K; Heidbreder E; Hummel S; Heidland A
    Z Kardiol; 1988; 77 Suppl 2():78-84. PubMed ID: 2970179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced secretion and impaired natriuretic action of atrial natriuretic peptide in response to hypertonic saline infusion in patients with essential hypertension.
    Akaike M; Nishiuchi T; Matsumoto N; Kawai H; Saito S
    J Hum Hypertens; 1994 Jan; 8(1):15-8. PubMed ID: 8151600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anteroventral third ventricle lesions impair cardiovascular responses to intravenous hypertonic saline infusion.
    Pedrino GR; Nakagawa Sera CT; Cravo SL; Colombari DS
    Auton Neurosci; 2005 Jan; 117(1):9-16. PubMed ID: 15620565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hypercalcemia on kidney function in anesthetized dogs.
    Kövér G; Tost H
    Acta Physiol Hung; 1993; 81(4):371-93. PubMed ID: 8067252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrarenal hypertonic saline infusions in dogs with thoracic caval constriction.
    Heidemann HT; Jackson EK; Gerkens JF; Branch RA
    Kidney Int; 1987 Oct; 32(4):488-92. PubMed ID: 3430950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of atrial natriuretic peptide during hypertonic saline infusion: the importance of posture.
    Burrell LM; Baylis PH
    Clin Endocrinol (Oxf); 1990 Apr; 32(4):491-6. PubMed ID: 2140735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstraton of a role of physical factors as determinants of the natriuretic response to volume expansion.
    Martino JA; Earley LE
    J Clin Invest; 1967 Dec; 46(12):1963-78. PubMed ID: 6074001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic factor inhibits hypertonic saline-mediated decreases in renal hemodynamics.
    Loftus JP; Redfield MM; Burnett JC
    Kidney Int; 1990 Aug; 38(2):227-31. PubMed ID: 2144881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and renal effects of atrial natriuretic peptide in patients with heart failure treated with angiotensin-converting enzyme inhibitor or in acute saline solution loading.
    Tomiyama H; Watanabe G; Abe M; Okazaki R; Yoshida H; Doba N
    Am Heart J; 2001 Mar; 141(3):422-7. PubMed ID: 11231440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.